MEAD, G.E.,
LEGG, L.,
TILNEY, R.,
HSIEH, C.F.,
WU, S.,
LUNDSTRÖM, E.,
RUDBERG, A.S.,
KUTLUBAEV, M.,
DENNIS, M.S.,
SOLEIMANI, B.,
BARUGH, A.,
HACKETT, M.L.,
HANKEY, G.J. (2020) , neurological deficits and
fatigue; improved motor function, mood, and cognition at the end of treatment
the acute phase of the disease. Even 12 months after recovery, unmotivated
fatigue, headache, mental